These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21507476)

  • 1. Improving tuberculosis diagnostics and treatment.
    Kranzer K
    Lancet; 2011 Apr; 377(9776):1467-8. PubMed ID: 21507476
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Jain A; Singh PK; Singh U; Kumar V
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):478-480. PubMed ID: 28284274
    [No Abstract]   [Full Text] [Related]  

  • 3. Xpert MTB/RIF test for tuberculosis.
    Salvo F; Sadutshang TD; Migliori GB; Zumla A; Cirillo DM
    Lancet; 2011 Aug; 378(9790):481-2; author reply 482-3. PubMed ID: 21821177
    [No Abstract]   [Full Text] [Related]  

  • 4. Xpert MTB/RIF test for tuberculosis.
    Ferrara G; O'Grady J; Zumla A; Maeurer M
    Lancet; 2011 Aug; 378(9790):482; author reply 482-3. PubMed ID: 21821179
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of tuberculosis].
    Rüsch-Gerdes S
    Internist (Berl); 1995 Oct; 36(10):957-60. PubMed ID: 7499071
    [No Abstract]   [Full Text] [Related]  

  • 6. How are we creating fluoroquinolone-resistant tuberculosis?
    Bernardo J; Yew WW
    Am J Respir Crit Care Med; 2009 Aug; 180(4):288-9. PubMed ID: 19661251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains].
    Zhukova MP
    Probl Tuberk; 1997; (5):12-5. PubMed ID: 9454239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic observation drug susceptibility (MODS): where are we going?
    Kam KM
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):127. PubMed ID: 24429301
    [No Abstract]   [Full Text] [Related]  

  • 9. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial drug resistance pattern among pulmonary tuberculosis patients.
    Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
    Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA; Farnia P; Masjedi MR; Hoffner S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 13. First case of primary multidrug-resistant pulmonary tuberculosis in a HIV-infected patient in Hungary.
    Sárvári C; Szlávik J; Bánhegyi D
    Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):635-6. PubMed ID: 13680395
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive.
    Rouzaud F; Robledo J
    Indian J Med Microbiol; 2010; 28(4):412-3. PubMed ID: 20966587
    [No Abstract]   [Full Text] [Related]  

  • 15. Xpert MTB/RIF test for tuberculosis.
    Theron G; Peter J; Dheda K
    Lancet; 2011 Aug; 378(9790):481; author reply 482-3. PubMed ID: 21821176
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance in Mycobacterium tuberculosis.
    Cole ST; Telenti A
    Eur Respir J Suppl; 1995 Sep; 20():701s-713s. PubMed ID: 8590570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving forward with evidence and controversies: the challenges of MDR-TB.
    Chiang CY; Van Deun A; Caminero JA
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):827. PubMed ID: 16898363
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
    Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
    Jonsson G; Furin J
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.